Literature DB >> 1696952

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.

W E Brandt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1696952     DOI： 10.1093/infdis/162.3.577

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  13 in total

1.  Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain.

Authors:  B Puri; S Polo; C G Hayes; B Falgout
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes.

Authors:  J T Roehrig; A J Johnson; A R Hunt; B J Beaty; J H Mathews
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes.

Authors:  J H Mathews; J T Roehrig; J R Brubaker; A R Hunt; J E Allan
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia.

Authors:  I Ratnam; J Black; K Leder; B-A Biggs; E Matchett; A Padiglione; I Woolley; T Panagiotidis; T Gherardin; L Pollissard; C Demont; C Luxemburger; J Torresi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-09       Impact factor: 3.267

5.  Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.

Authors:  S Butrapet; C Y Huang; D J Pierro; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus.

Authors:  J H Mathews; J E Allan; J T Roehrig; J R Brubaker; M F Uren; A R Hunt
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form.

Authors:  S L Allison; K Stadler; C W Mandl; C Kunz; F X Heinz
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus.

Authors:  R J Phillpotts; K Venugopal; T Brooks
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Expression of cloned envelope protein genes from the flavivirus tick-borne encephalitis virus in mammalian cells and random mutagenesis by PCR.

Authors:  S L Allison; C W Mandl; C Kunz; F X Heinz
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

10.  Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells.

Authors:  C Delenda; M P Frenkiel; V Deubel
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.